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Synthesis and Characterization of Poly-NHC-Derived Silver
(I) Assemblies and Their Transformation into Poly-
Imidazolium Macrocycles
Ana Gutiérrez-Blanco,[a, b] Christian Dobbe,[a] Alexander Hepp,[a] Constantin G. Daniliuc,[c]
Macarena Poyatos,*[b] F. Ekkehardt Hahn,*[a] and Eduardo Peris*[b]
Three metallosupramolecular assemblies composed of two bis-
NHCs and two silver atoms, [4](PF6)2, two tetra-NHCs and four
silver atoms, [7](PF6)4, and two tri-NHCs and three silver atoms
[8](BF4)3, have been prepared. Assemblies [4](PF6)2 and [7](PF6)4
feature NHC ligands decorated with terminal olefin groups.
Irradiation of [4](PF6)2 yielded complex [5](PF6)2 with two
terminal cyclobutane rings linking the two bis-NHC ligands.
Liberation of the macrocyclic tetrakisimidazolium salt H4-6(PF6)4
was achieved by reaction of [5](PF6)2 with NH4Cl/NH4PF6. No [2
+2] cycloaddition was observed upon irradiation of [7](PF6)4,
apparently due to an unfavorable orientation of the olefin
groups. Irradiation of complex [8](BF4)3 with three internal pairs
of olefin groups leads to [9](BF4)3 as a mixture of two isomers
that differ on the relative orientation of the internal cyclobutane
rings. Reaction of [9](BF4)3 with NH4Cl/NH4BF4 yields an isomer
mixture of the novel cage-line hexakisimidazolium salt H6-
10(BF4)6.
Introduction
Over the last three decades, research on supramolecular
coordination complexes (SCCs)[1] has emerged as an important
sub-discipline of coordination chemistry. Particularly, the wide
range of applications has stimulated interest in these com-
pounds. Among others, SCCs have found applications in
catalysis,[2] molecular recognition,[3] the stabilization of highly
reactive species,[4] and as drug delivery/release vectors.[5]
Coordination-driven self-assembly[1e,6] arguably constitutes the
most widely used method for the construction of discrete SCCs.
From the ligand perspective, metallosupramolecular assemblies
have been mainly constructed from O-, N-, and P-donor
Werner-type polydentate ligands. More recently, poly N-hetero-
cyclic carbene ligands (poly-NHCs)[7] have emerged as an
alternative for the generation of organometallic metallosupra-
molecular assemblies.[8] The rapid development of organo-
metallic supramolecular assemblies is illustrated by the coinage
of the term supramolecular organometallic complexes (SOCs),[9]
referring to all metal-containing assemblies in which the linker-
metal connection is established by M  C bonds.
Over the last 10 years, the number of metallosupramolecu-
lar assemblies featuring M  CNHC bonds has grown steadily.
Among them, a large number of NHC-derived SOCs is based on
group 11 metals. These metals in oxidation state of +1 offer
certain advantages for the preparation of metal assemblies such
as the trend to form linear CNHC  M  CNHC moieties and therefore
facilitate the construction of assemblies in which the metal is
sandwiched between two polydentate NHCs.[10] In addition, the
Ag  CNHC bond is usually labile allowing rearrangements to the
thermodynamically most stable assembly. Known poly-NHC
derived assemblies with group 11 metals, include diverse
architectures such as rectangles, triangles[11] and cylinders.[12]
Metallosupramolecular assemblies that are amenable of
post-assembly modification (PAM) reactions can be modified at
their ligands after the assembly has formed.[8a,12h,13] This
constitutes a very interesting feature, because PAM reactions
facilitate the generation of architectures with tailored function-
alities normally not directly accessible from metal ions and
ligands. The combination of poly-NHC ligands and group 11
metals has been found to be a promising strategy for the
design of PAM-amenable metallosupramolecular
assemblies.[8a,14]
Cationic imidazolium salts have been widely used as anion
receptors because they combine potential hydrogen bonding
with favorable electrostatic interactions in their interactions
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with selected substrates.[15] However, finding effective ways for
preparing imidazolium-based multivalent anion receptors still
constitutes a challenge. The PAM methodology may constitute
a valuable approach for the preparation of poly-imidazolium
salts as anion receptors with enhanced binding affinities, as
suggested by Jin and co-workers.[14d] Our first progress in this
area was recently described with the template-controlled
preparation of an oktakisimidazolium salt starting from a
tetrakisimidazolium salt.[14a] The oktakisimidazolium salt turned
out to be an efficient multivalent anion receptor with a binding
affinity significantly larger than that shown by the original
tetrakisimidazolium salt.
Based on these previous findings, we describe here the
preparation and characterization of a series of metallosupramo-
lecular assemblies from poly-imidazolium salts featuring termi-
nal or internal olefins and AgI ions. The resulting poly-NHC-AgI
assemblies were then subjected to photochemically induced [2
+2] cycloaddition reactions, by activation of the pendant
cinnamic ester groups or the internal olefins. This procedure
linked the individual poly-NHC ligands to larger macrocyclic or
cage-like poly-NHCs. Demetallation of the poly-NHC complexes
yielded novel poly-imidazolium salts not accessible by conven-
tional organic synthesis.
Results and Discussion
The poly-imidazolium salts H2-1(PF6)2 and H4-2(PF6)4 (Scheme 1,
top) featuring terminal olefins were prepared by standard
methods from the bis- or tetrakisimidazolyl compounds by N-
alkylation with methyl-3-(4-bromomethyl)cinnamate. A different
strategy was used for the preparation of H3-3(Br)3 featuring
internal olefins (Scheme 1, bottom). First 1,3,5-tris
(diethoxyphosphinylmethylene)benzene was reacted with 4-
imidazolylbenzaldehyde in the presence of KOtBu.[14a] The
trisimidazolyl derivative was then triply N-alkylated using nBuBr
to give H3-3(Br)3 in 83% yield. The poly-imidazolium salts H2-
1(PF6)2-H3-3(Br)3 were characterized by NMR spectroscopy and
mass spectrometry.
Reaction of H2-1(PF6)2 with a slight excess of Ag2O yielded
the metallorectangle [4](PF6)2 in 83% yield (Scheme 2). The
formation of the rectangular assembly was confirmed by NMR
spectroscopy and mass spectrometry. The 1H NMR spectrum of
[4](PF6)2 is consistent with the pseudo-D2h symmetry of the
molecule. This is exemplified by the appearance of two
resonances assigned to the protons of the imidazolylidene rings
(δ=7.98 and 7.78 ppm), the three signals due to the protons of
the terphenylene linker (δ=7.88, 7.80 and 7.64 ppm) and the
two doublets assigned to the olefin protons (δ=7.52 and
6.48 ppm). The metallation of the NHC donors with AgI has
been confirmed by the resonance at δ=179.4 ppm observed in
the 13C{1H} NMR spectrum for the CNHC carbon atom. The
dimetallic nature of the complex is evident from the electro-
spray mass spectrum, which shows the base peak at m/z=
818.4, assigned to [4]2+.
The dinuclear NHC complex [4](PF6)2 was irradiated at
ambient temperature with a high pressure mercury lamp for 3 h
in acetonitrile to initiate a [2+2] cycloaddition of two adjacent
cinnamic acid groups. Under these reaction conditions, [4](PF6)2
was quantitatively converted into complex [5](PF6)2 featuring
two cyclobutane units linking the two p-terphenylene-bisimida-
zolylidene ligands (Scheme 2). The 1H NMR spectrum of [5](PF6)2
lacks the signals due to the olefin protons that were observed
for [4](PF6)2 at δ=7.52 and 6.48 ppm. Instead, two new
resonances at δ=4.25 and 4.08 ppm for the protons of the
cyclobutane rings are observed, confirming that the [2+2]
cycloaddition did proceed (Figure 1).
Finally, the two AgI cations in [5](PF6)2 were removed by
reaction with NH4Cl in methanol to give the soluble macrocyclic
tetrakisimidazolium salt H4-6(Cl)4 and solid AgCl. Anion ex-
change with NH4PF6 allowed precipitating H4-6(PF6)4 in 80%
yield (Scheme 2). The 1H NMR spectrum of H4-6(PF6)4 showed
the characteristic signal for the four chemically equivalent
NCHN protons of the imidazolium groups at δ=10.02 ppm as a
clear indication for the formation of four imidazolium units
(Figure 1). The signals for the cyclobutane protons were
observed as doublets at δ=4.31 and 4.06 ppm. The ESI mass
spectrum of H4-6(PF6)4 showed the most intensive peaks at m/




Next, the tetranuclear metallocage [7](PF6)4 was prepared
from the pyrene-bridged tetrakisimidazolium salt H4-2(PF6)4 and
Ag2O (Scheme 3). In previous studies, we observed a series of
Scheme 1. Poly-imidazolium salts H2-1(PF6)2 and H4-2(PF6)4 (top), and
synthetic procedure for the preparation of H3-3(Br)3 (bottom).
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tetranuclear RhI and IrI complexes obtained from a related
pyrene-bridged tetrakisimidazolylidene ligand displaying inter-
esting structural and catalytic features.[16] The reaction of H4-
2(PF6)4 with Ag2O, affords the tetranuclear cylinder-like assem-
bly [7](PF6)4 in 74% yield. Compound [7](PF6)4 was characterized
by NMR spectroscopy and mass spectrometry. The 1H NMR
spectrum displays a set of signals in accord with a pseudo-D2h
symmetric molecule. For example, two resonances due to the
protons of the pyrene bridge were observed at δ=8.18 and
7.96 ppm. In addition, two signals due to the protons of the
imidazolylidene rings (δ=7.56 and 7.45 ppm) and two doublets
assigned to the olefin protons (δ=7.52 and 6.39 ppm) were
observed. The 13C{1H}NMR spectrum shows a signal at δ=
182.8 ppm assigned to the metallated carbene carbon atom.
The tetrametallic nature of the complex was unambiguously
confirmed by electrospray mass spectrometry, which reveals
peaks at m/z=689.6 and 967.8 assigned to [7]4+ and [7+PF6]3+,
respectively.
Attempts to perform a post synthetic modification on
[7](PF6)4 via a photochemically induced [2+2] cycloaddition
reaction were next investigated. A solution of [7](PF6)4 in
acetonitrile was irradiated with a high pressure mercury lamp at
ambient temperature for 3 h. Under these reaction conditions,
the expected cycloaddition product was not formed and only a
mixture of unidentified reaction products was obtained. For the
[2+2] cycloaddition to proceed, the olefins must be oriented in
a parallel fashion with a distance between the midpoints
measuring about 3.6 Å.[17] While these geometric features were
observed for a related cylinder-like assembly obtained from two
tetra-NHC ligand and four silver atoms,[14a] we believe that the
orientation of the olefin groups in [7](PF6)4 does not meet the
geometric requirements. Unfortunately, we were not able to
obtain crystals suitable for an X-ray diffraction study with
[7](PF6)4 to confirm this assumption.
In order to shed more light on the geometric requirements
for the [2+2] cycloaddition and the possible outcome of this
reaction, we decided to extend our studies to tri-NHC ligands
featuring internal olefin groups. In this regard, the reaction of
H3-3(Br)3 with Ag2O followed by anion exchange with AgBF4
yielded assembly [8](BF4)3 (Scheme 4). Complex [8](BF4)3 was
characterized by NMR spectroscopy. The 13C{1H} NMR spectrum
shows the characteristic resonance for the CNHC carbon atom at
δ = 178.0 ppm. The 1H NMR spectrum features the resonances
for the olefin protons at δ = 7.19 and 7.14 ppm with the typical
trans-coupling constant of 3JH-H = 16.5 Hz.
The molecular structure of [8](BF4)3 was established by an X-
ray diffraction analysis with crystals of composition
[8](BPh4)3·2CH3CN obtained from [8](BF4)3 by anion exchange
with NaBPh4. The molecular structure determination confirms
the formation of a cylinder-like, trinuclear assembly (Figure 2).
Scheme 2. Preparation of the metallosupramolecular assembly [4](PF6)2, its
PAM to give [5](PF6)2 and liberation of the macrocyclic tetrakisimidazolium
salt H4-6(PF6)4.
Scheme 3. Synthesis of [7](PF6)4 and attempted PAM.
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The three silver atoms form a rather symmetrical triangle
with an average non-bonding Ag···Ag separation of 17.6 Å. The
average Ag  CNHC distance measures 2.08 Å and falls in the
typical range for this type of bond.[14] The central benzene rings
are arranged parallel but twisted by about 4° relative to each
other. Interestingly, the three pairs of olefin groups are not
oriented in a parallel fashion.
While the separation between the olefins in the three pair
measures between 3.35 to 3.83 Å and thus fall in the range
required for a subsequent [2+2] cycloaddition,[17] their non-
parallel orientation might prevent this reaction. Such behavior
has been previously observed for dinuclear silver-NHC com-
plexes featuring internal olefin bonds.[14f]
Nevertheless, complex [8](BF4)3 was irradiated with a high-
pressure lamp in order to prove our hypothesis. We observed
changes in the 1H NMR spectra, thus indicating that the
cycloaddition reaction might be taking place. After 16 h of
reaction, no more changes were observed in the 1H NMR and it
was assumed that the formation of the triple cyclobutane was
complete (Scheme 4).
This assumption was corroborated by the 1H NMR spectrum
of the reaction product [9](BF4)3, showing no resonances for the
olefin protons. However, the 1H NMR spectrum features a total
of 12 new resonances for the cyclobutane protons (Figure 3)
instead of the two resonances expected and observed after
cyclobutane formation in [5](PF6)2 and related compounds.[14]
This observation is consistent with the formation of two
isomeric complexes (Figure 4) in the cycloaddition, featuring
either three different (isomer A) or three identical cyclobutane
rings (isomer B).
Assuming the formation of the isomers A and B of [9](BF4)3,
all resonances in the 1H NMR spectrum (Figure 3, bottom) can
be assigned. For the unsymmetric isomer A, three resonances
are observed for each of the protons H10, H11 and H13. The
symmetric isomer B gives only one set of resonances for H10,
H11 and H13. The resonances for the other protons of the
isomers fall together in additional multiplets, which could not
be resolved.
Figure 1. Section of the 1H NMR spectra (DMSO-d6) of (a) H2-1(PF6)2, (b) [4](PF6)2, (c) [5](PF6)2 and (d) H4-6(PF6)4. Only characteristic signals mentioned in the
text are labelled in the spectra.
Figure 2. Molecular structure of cation [8]3+ in [8](BPh4)3·2CH3CN showing
the non-parallel orientation of the olefin groups (in red).
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The formation of the isomer mixture should lead to two
separate spin systems. These two spin systems were indeed
observed by 1H,1H-ROESY NMR spectroscopy (Figure 5). The
ROESY spectrum clearly shows the correlation between protons
H13 and H10/H11 for the two isomers. Resonances for the
isomer mixture of [9](BF4)3 were also observed by 13C{1H} NMR
spectroscopy (see the Supporting Information).
Finally, the hexakisimidazolium salt H6-10(BF4)6 was liber-
ated from compound [9](BF4)3 by reaction with NH4Cl/NH4BF4 in
methanol (Scheme 4). The salt was characterized by mass
spectrometry showing the strongest peaks at m/z (%)=
251.1542 (100, calcd. for [H6-10]
6+ 251.1548) and 318.9866 (40,
calcd. for [H6-10+BF4]
5+ 318.9872). Both the 1H and the 13C{1H}
NMR spectra of H6-10(BF4)6 confirm the presence of two
isomers, one featuring three different cyclobutane rings and
Scheme 4. Synthesis of [8](BF4)3, its PAM to [9](BF4)3 and liberation of
hexakisimidazolium salt H6-10(BF4)6.
Figure 3. Sections of the 1H NMR spectra of [8](BF4)3 (top) and [9](BF4)3
(bottom). The resonances for isomers A and B are labelled in blue and red,
respectively. Overlapping resonances for both isomers are depicted in black.
Figure 4. Schematic representation of isomers A and B of [9](BF4)3.
Figure 5. Section of the 1H,1H ROESY NMR spectrum for the isomers of
[9](BF4)3 showing the two independent spin systems (resonances for the
unsymmetrical isomer A in blue and for the symmetrical isomer B in red).
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one composed of three identical ones, similar to the situation in
[9](BF4)3 (see the Supporting Information).
Conclusions
In summary, new bis- and tetrakisimidazolium salts with
terminal olefins and a trisimidazolium salt with internal olefins
have been prepared and used for the synthesis of di-, tetra- and
trinuclear silver-NHC assemblies. The di-silver tetra-NHC metal-
lorectangle [4](PF6)2 underwent effective photochemically in-
duced [2+2] cycloaddition to form a new macrocycle in which
the two di-NHC ligands are linked by two terminal cyclobutane
units. Removal of the AgI ions with NH4Cl/NH4PF6 afforded a
novel macrocyclic tetrakisimidazolium salt H4-6(PF6)4. The pyr-
ene-bridged tetrakismidazolium salt H4-2(PF6)4 reacted with
Ag2O to give the cylinder-like tetrasilver assembly [7](PF6)4
featuring four pairs of terminal olefins. Irradiation of this
assembly did not yield the derivative with bridging cyclo-
butanes, most likely due to an unfavorable orientation of the
olefin groups. Finally, trisimidazolium salt H3-3(Br)3 reacted with
Ag2O to give the trinuclear assembly [8](BF4)3 featuring three
internal pairs of olefins. Irradiation of this assembly proceeded
via triple cyclobutane formation leading to a mixture of two
isomeric complexes [9](BF4)3 with either three different or three
identical cyclobutane linkers. Liberation of two isomeric
hexakisimidazolium cages from [9](BF4)3 proved possible. We
present an efficient method for the synthesis of macrocyclic or
cage-like poly-imidazolium salts via photochemical [2+2] cyclo-
addition at a silver-carbene template. We are confident that this
methodology can be extended to the synthesis of novel cyclic
poly-azolium salts not accessible by conventional organic
synthesis.
Experimental Section
General considerations. 1,3,6,8-Tetraimidazolylpyrene was prepared
according to a reported method.[16] All other reagents were used as
received from commercial suppliers. Anhydrous solvents were dried
using a solvent purification system (SPS M BRAUN) or were distilled
by standard procedures prior to use. NMR spectra were recorded
on Bruker AVANCE III 400 or 300 MHz spectrometers. NMR spectra
were obtained at room temperature in acetonitrile-d3 or DMSO-d6.
Electrospray mass spectra were recorded on a Micromass Quatro LC
instrument, MeOH or CH3CN were used as mobile phase, and
nitrogen was employed as drying and nebulizing gas. Satisfactory
microanalytical data for most ligands and metal complexes could
not be obtained due to the large fluorine content in the
hexafluorophosphate counterions. A complete set of NMR spectra
is provided instead.
Synthesis of bisimidazolyl-p-terphenylene
4,4’-Dibromoterphenyl (500 mg, 1.29 mmol), imidazole (173 mg,
2.54 mmol), K2CO3 (710 mg, 5.14 mmol) and CuI (49 mg, 0.26 mmol)
were placed together in a high pressure Schlenk tube fitted with a
Teflon cap. The tube was evacuated and filled with nitrogen three
times. The solids were suspended in anhydrous DMF (20 mL) and
the resulting mixture was heated under reflux for 72 h. The reaction
mixture was then allowed to reach ambient temperature. Distilled
water (75 mL) was added, and the resulting suspension was stirred
for 2 h. The solid was collected by filtration and washed with water.
Compound bisimidazolyl-p-terphenylene was isolated as a white
solid. Yield: 440 mg (1.21 mmol, 94%). 1H NMR (400 MHz, DMSO-d6):
δ=7.89–7.83 (m, 8H (2H H4, 4H H7, 2H H2)), 7.80–7.66 (m, 10H (2H
H5, 8H H8, H11)). ESI MS m/z=362.7 (calcd. for [M]+ 362.2).
Synthesis of H2-1(PF6)2
Bisimidazolyl-p-terphenylene (80 mg, 0.22 mmol) and methyl 3-(4-
bromomethyl)cinnamate (113 mg, 0.44 mmol) were placed togeth-
er in a thick-walled Schlenk tube fitted with a Teflon cap. The tube
was evacuated and filled with nitrogen three times. The solids were
suspended in anhydrous DMF (16 mL) and the resulting mixture
was heated to 145 °C for 24 h. Once at ambient temperature, the
solvent was distilled under vacuum. The resulting white solid was
washed several times with diethyl ether and dried under vacuum.
The obtained bromide salt H2-1(Br)2 (101 mg, 0.12 mmol) was
suspended in MeOH (20 mL), heated to 40 °C and treated with
NH4PF6 (56 mg, 0.34 mmol). The resulting suspension was stirred at
40 °C for 16 h. Filtration of the suspension yielded compound H2-
1(PF6)2 as a light brown solid. Yield: 154 mg (0.15 mmol, 68%).
1H
NMR (300 MHz, DMSO-d6): δ=10.02 (s, 2H, H2), 8.42 (s, 2H, H4),
8.09–8.06 (m, 6H (2H, H5; 4H, H11), 7.93 (m, 8H, H7 and H8), 7.83 (d,
3JH-H=8.2 Hz, 4H, H14), 7.70 (d,
3JH-H=16.1 Hz, 2H, H17), 7.58
(d, 3JH-H=8.2 Hz, 4H, H15), 6.72 (d,
3JH-H=16.1 Hz, 2H, H18), 5.55 (s,
4H, H12), 3.73 (s, 6H, H20). 13C {1H} NMR (75 MHz, DMSO-d6): δ=
166.6 (C19), 143.7 (C17), 140.6, 138.1, 136.5 (C6, C9, C10), 135.7 (C2),
134.6, 134.1, 129.0, 128.9 (C13, C14, C15, C16), 128.1, 127.6 (C7, C8),
122.5 (C11, C5), 121.7 (C4), 118.7 (C18), 52.14 (C12), 51.54 (C20). 19F
{1H NMR (282 MHz, DMSO-d6): δ=   70.2 (d).
31P{1H} NMR (121 MHz,
DMSO-d6): δ=   144.2 (m). ESI MS m/z=355.9 (calcd. for [H2-1]2+
356. 2), 857.3 (calcd. for [H2-1+PF6]
+ 857.3).
Synthesis of H4-2(PF6)4
The neutral precursor 1,3,6,8-tetraimidazolylpyrene (100 mg,
0.21 mmol) and methyl 3-(4-bromomethyl)cinnamate (230 mg,
0.90 mmol) were placed together in a thick-walled Schlenk tube
fitted with a Teflon cap. The tube was evacuated and filled with
nitrogen three times. The solids were suspended in anhydrous DMF
(20 mL) and the resulting mixture was heated to 145 °C for 24 h.
Once at ambient temperature, the solvent was distilled. The
resulting brown solid was washed several times with diethyl ether
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and dried under vacuum. The obtained bromide salt H4-2(Br)4
(267 mg, 0.18 mmol) was suspended in MeOH (30 mL), heated at
40 °C and treated with NH4PF6 (176 mg, 1.1 mmol). The suspension
was stirred at 40 °C for 16 h. Compound H4-2(PF6)4 was collected by
filtration as a brown solid. Yield: 225 mg (0.13 mmol, 61%). 1H NMR
(400 MHz, CD3CN): δ=9.14 (s, 4H, H2), 8.59 (s, 2H, H10), 8.27 (s, 4H,
H8), 7.92 (s, 4H, H5), 7.83 (s, 4H, H4), 7.75 (d, 3JH-H=7.7 Hz, 8H, H14),
7.73 (d, 3JH-H=16 Hz, 4H, H16), 7.61 (d,
3JH-H=7.7 Hz, 8H, H13), 6.60
(d, 3JH-H=16 Hz, 4H, H17), 5.61 (s, 8H, H11), 3.77 (s, 12H, H19).
13C
{1H} NMR (101 MHz, CD3CN): δ=167.9 (C18), 144.3 (C16), 138.8 (C2),
136.6 (C15), 135.9 (C12), 131.0 (C6), 130.8 (C13), 130.7 (C9), 130.02
(C14), 128.9 (C7), 126.8 (C10), 126.7 (C5), 125.9 (C8), 124.8 (C4),
120.4 (C17), 54.4 (C11), 52.4 (C19). 19F{1H} NMR (376 MHz, CD3CN):
δ=   72.6 (d). 31P{1H} NMR (162 MHz, CD3CN): δ=   144.6 (m). ESI
MS m/z=437.1 (calcd. for [H4-2+PF6]3+ 437.1), 728.2 (calcd. for [H4-
2+2PF6]2+ 728.2).
Synthesis of H3-3(Br)3
A solution of potassium tert-butoxide (2.76 g, 24.6 mmol) in THF
(50 mL) was added slowly to a solution of 4-imidazolbenzaldehyde
(2.12 g, 12.3 mmol) and 1,3,5-tris
(diethoxyphosphosphinylmethylen)benzene (1.30 g, 2.46 mmol) in
THF (50 mL) at 0 °C. The solution was stirred for 1 h at 0 °C and was
then slowly warmed to 25 °C for 12 h while stirring. Methanol
(25 mL) and water (25 mL) were added to the reaction mixture,
leading to the precipitation of a light brown solid. The solid was
isolated by filtration and washed with diethyl ether (3×15 mL). The
solid was dried under vacuum to give the trisimidazole. Yield 1.0 g
(1.72 mmol, 70%). The so-isolated trisimidazole (500 mg,
0.86 mmol) was reacted with 1-bromobutane (3.59 g, 2.8 mL,
26.2 mmol) in DMF (40 mL). The suspension was stirred at 120° C
for 72 h, then allowed to reach ambient temperature and filtered.
The obtained solid was washed with DMF (2×10 mL), acetone (3×
15 mL) and diethyl ether (3×15 mL). The solid was dried under
vacuum to give compound H3-3(Br)3 as a light brown solid. Yield:
0.71 g (0.71 mmol, 83%). 1H NMR (400 MHz, DMSO-d6): δ=10.02 (s,
3H, H2), 8.40 (s, 3H, H5), 8.10 (s, 3H, H4), 7.95 (d, 3JH-H=8.5 Hz, 6H,
H8), 7.89 (s, 3H, H13), 7.87 (d, 3JH-H=8.5 Hz, 6H, H7), 7.58 (d,
3JH-H=
16.5 Hz, 3H, H11), 7.51 (d, 3JH-H=16.5 Hz, 3H, H10), 4.27 (t,
3JH-H=
7.4 Hz, 6H, H14), 1.91 (m, 6H, H15), 1.37 (m, 6H, H16), 0.96 (t, 3JH-H=
7.4 Hz, 9H, H17). 13C{1H} NMR (101 MHz, DMSO-d6): δ=138.3 (C9),
137.5 (C12), 135.1 (C2), 133.6 (C6), 130.0 (C11), 127.8 (C8), 127.6
(C10), 124.7 (C13), 123.3 (C4), 122.0 (C7), 120.8 (C5), 49.0 (C14), 31.0
(C15), 18.8 (C16), 13.2 (C17). HRMS (ESI, positive ions): m/z (%)=
251.1543 (100, calcd. for [H3-3]3+ 251.1548).
Synthesis of [4](PF6)2
Ag2O (70 mg, 0.3 mmol) was added to a solution of H2-1(PF6)2
(100 mg, 0.1 mmol) in acetonitrile (30 mL). The mixture was stirred
under exclusion of light for 48 h at 70 °C. After reaching ambient
temperature, the obtained suspension was filtered through Celite.
The filtrate was concentrated. Addition of diethyl ether yielded
[4](PF6)2 as a grey solid which was collected by filtration, washed
with diethyl ether and dried under vacuum. Yield: 80 mg
(0.042 mmol, 83%). 1H NMR (400 MHz, DMSO-d6): δ=7.98 (s, 4H,
H5), 7.88 (d, 3JH-H=8.3 Hz, 8H, H11), 7.80 (d,
3JH-H=8.3 Hz, 8H, H7),
7.78 (s, 4H, H4), 7.64 (s, 8H, H8), 7.55 (d, 3JH-H=8 Hz, 8H, H14),
7.52 (d, 3JH-H=16 Hz, 4H, H17), 7.20 (d,
3JH-H=8 Hz, 8H, H15), 6.48 (d,
3JH-H=16 Hz, 4H, H18), 5.45 (s, 8H, H12), 3.72 (s, 12H, H20).
13C {1H}
NMR (101 MHz, DMSO-d6): δ=179.4 (C2), 166.4 (C19), 143.6 (C17),
139.0, 138.8, 138.7, 137,5, 133,7 (C6, C9, C10, C13, C16), 128.6 (C14),
127.41 (C7), 127.38 (C15), 126.9 (C11), 124.1 (C8), 123.6 123.1 (C4,
C5), 117.9 (C18), 54.4 (C12), 51.4 (C20). 19F{1H} NMR (376 MHz,
DMSO-d6): δ=   70.2 (d).
31P{1H} NMR (162 MHz, DMSO-d6): δ=
  144.2 (m). ESI MS m/z=818.4 (calcd. for [4]2+ 818.2).
Synthesis of [5](PF6)2
A quartz tube was charged with a sample of [4](PF6)2 (18 mg,
0.009 mmol) and CH3CN (10 mL). Under air and at ambient temper-
ature, the solution was irradiated with a Philips high-pressure
mercury lamp for 3 h. The solution was then filtered through Celite
and the filtrate was concentrated under vacuum. Conversion was
quantitative as judged from the 1H NMR data. 1H NMR (400 MHz,
DMSO-d6): δ=7.94 (s, 4H, H5), 7.80 (d,
3JH-H=8.4 Hz, 8H, H8), 7.77 (s,
4H, H4), 7.74 (d, 3JH-H=8.4 Hz, 8H, H7), 7.55 (s, 8H, H11), 6.81 (br s,
16H, H14, H15), 5.49 (s, 8H, H12), 4.25 (s, 4H, H17), 4.08 (s, 4H, H18),
3.68 (s, 12H, H20).
Synthesis of H4-6(PF6)4
NH4Cl (2 mg, 0.038 mmol) was added to a solution of [5](PF6)2
(18 mg, 0.009 mmol) in MeOH (10 mL), and the mixture was stirred
for 1 h. The suspension was then filtered and NH4PF6 (6 mg,
0.037 mmol) was added to the filtrate. After stirring the mixture for
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another 2 h, the desired tetrakisimidazolium salt precipitated. The
salt was isolated by filtration, washed with diethyl ether and dried
under vacuum to give H4-6(PF6)4 as a white solid. Yield: 13.7 mg
(0.0072 mmol, 80%). 1H NMR (300 MHz, CD3CN): δ=8.80 (s, 4H, H2),
7.74 (d, 3JH-H=8.6 Hz, 8H, H8), 7.59 (m, 12H (8H, H11; 4H, H5)), 7.49
(d, 3JH-H=8.6 Hz, 8H, H7), 7.21 (d,
3JH-H=8.1 Hz, 8H, H14), 7.10 (d,
3JH-
H=8.1 Hz, 12H (8H, H15; 4H H4), 5.13 (s, 8H, H12), 4.42 (d,
3JH-H=
6.1 Hz, 4H, H17), 3.97 (d, 3JH-H=6.1 Hz, 4H, H18) 3.71 (s, 12H, H20).
13C {1H} NMR (101 MHz, CD3CN): δ=173.7 (C19), 142.3, 141.3, 139.0,
135.1 (C6, C9, C10, C13), 134.7 (C2), 131.6 (C16), 129.9 (C14), 129.9
(C15), 129.3 (C7), 128.4 (C11), 123.5 (C5), 123.3 (C8), 122.5 (C4), 53.8
(C12), 52.7 (C20), 45.7 (C18), 43.2 (C17). 19F {1H} NMR (282 MHz,
CD3CN): δ=   72.8 (d).
31P {1H} NMR (121 MHz, CD3CN): δ=   144.6
(m). ESI MS m/z=356.0 (calcd. for [H4-6]




Under aerobic conditions, Ag2O (39.6 mg, 0.171 mmol) was added
to a solution of H4-2(PF6)4 (100 mg, 0.057 mmol) in acetonitrile
(20 mL). The mixture was stirred under exclusion of light for 72 h at
70 °C. After reaching ambient temperature, the resulting suspension
was filtered through Celite. The filtrate was concentrated, and
addition of diethyl ether (15 mL) produced a grey solid, which was
collected by filtration, washed with diethyl ether, and dried under
vacuum. Yield 70 mg (0.021 mmol, 74%). 1H NMR (400 MHz,
CD3CN): δ=8.18 (s, 4H, H10), 7.96 (s, 8H, H8), 7.56 (s, 8H, H5), 7.52
(d, 3JH-H=16 Hz, 8H, H16), 7.45 (m, 24H (16H, H13; 8H, H4)), 7.22 (d,
3JH-H=7.8 Hz, 16H, H14), 6.39 (d,
3JH-H=16 Hz, 8H, H17), 5.43
(d, 2JH-H=6 Hz, 16H, H11), 3.78 (s, 24H, H19).
13C {1H} NMR (101 MHz,
CD3CN): δ=182.8 (C2), 167.9 (C18), 144.3 (C16), 139.4 (C6), 135.5
(C12), 135.3 (C15), 129.9 (C9), 129.7 (C13), 129.6 (C7), 128.5 (C14),
127.4 (C10), 127.0 (C8), 124.2 (C4), 124.2 (C5), 119.5 (C17), 55.7
(C11), 52.4 (C19). 19F {1H} NMR (376 MHz, CD3CN): δ=   72.5 (d).
31P
{1H} NMR (162 MHz, CD3CN): δ=   144.6 (m). ESI MS m/z=689.6
(calcd. for [7]4+ 689.4), 967.8 (calcd. for [7+PF6]
3+ 967.5).
Synthesis of [8](BF4)3
A mixture of H3-3(Br)3 (99 mg, 0.10 mmol) and Ag2O (37 mg,
0.16 mmol) in methanol (10 mL) was stirred at 55 °C under
exclusion of light for 16 h. The solvent was then removed under
reduced pressure and AgBF4 (29 mg, 0.15 mmol) and acetonitrile
(10 mL) were added. The solution was then stirred for 12 h at 55 °C.
Subsequently, the suspension was filtered twice trough Celite. The
solvent was removed under reduced pressure and the remaining
solid was dissolved in CH2Cl2 (5 mL). This solution was again filtered
through Celite. The filtrate was brought to dryness to give
compound [8](BF4)3 as a light brown solid. Yield: 98 mg
(0.047 mmol, 94%). 1H NMR (400 MHz, DMSO-d6): δ=7.95 (d,
3JH-H=
1.6 Hz, 6H, H5), 7.85 (d, 3JH-H=1.6 Hz, 6H, H4), 7.66 (d,
3JH-H=8.5 Hz,
12H, H7), 7.51 (d, 3JH-H=8.5 Hz, 12H, H8), 7.37 (s, 6H, H13), 7.19 (d,
3JH-H=16.5 Hz, 6H, H10), 7.14 (d,
3JH-H=16.5 Hz, 6H, H11), 4.36
(t, 3JH-H=6.9 Hz, 12H, H14), 2.02–1.88 (m, 12H, H15), 1.48–1.36 (m,
12H, H16), 1.00 (t, 3JH-H=7.3 Hz, 18H, H17).
13C{1H} NMR (101 MHz,
DMSO-d6): δ=178.0 (br, C2), 138.1 (C6), 137.1 (C9), 136.8 (C12),
129.4 (C11), 127.2 (C8), 126.8 (C10), 124.1 (C13), 123.1 (C4, C7),
122.1 (C5), 51.6 (C14), 33.2 (C15), 19.4 (C16), 13.5 (C17). HRMS (ESI,
positive ions): m/z (%)=608.5316 (100, calcd. for [8]3+ 608.5332).
Anal. Calcd. for [8](BF4)3·H2O (C102H108 Ag3N12B3F12·H2O): C, 58.22; H,
5.27; N, 7.99. Found: C, 57.92; H, 4.79; N, 8.11%.
Synthesis of [9](BF4)3
A solution of [8](BF4)3 (98 mg, 0.047 mmol) in CH3CN (50 mL) was
placed in a quartz Schlenk tube. The solution was irradiated with a
Philips high-pressure mercury lamp for 16 h at 25 °C. The
suspension was subsequently filtered through Celite and the filtrate
was brought to dryness to give compound [9](BF4)3 as an brownish
solid. The conversion from [8](BF4)3 to [9](BF4)3 was quantitative as
judged by 1H NMR spectroscopy. The NMR spectra indicated the
formation of 2 isomers depending on the conformation of the
cyclobutane rings. The two isomers could not be separated, but
their resonances in the NMR spectra were resolved based on 2D
NMR data. Due to signal overlap, the relative amounts of the
isomers could not be determined exactly. 1H NMR (400 MHz,
CD3CN, isomer A with three different cyclobutanes): δ=7.48–7.33
(m, 12H, H4, H5), 7.32–7.16 (m, 24H, H7, H8), 6.98 (s, 2H, H13), 6.50
(s, 2H, H13’), 5.95 (s, 2H, H13’’), 4.96 (d, 3JH-H=6.2 Hz, 2H H10), 4.92
(d, 3JH-H=6.2 Hz, 2H, H10’), 4.81 (d,
3JH-H=6.5 Hz, 2H, H11), 4.60 (d,
3JH-H=6.7 Hz, 4H, H10’’, H11’), 4.53 (d,
3JH-H=6.5 Hz, H11’’), 4.32–4.22
(m, 12H, H14), 1.96–1.93 (m, 12H, H15), 1.51–1.37 (m, 12H, H16),
1.04–0.96 (m, 18H, H17). 13C{1H} NMR (101 MHz, CD3CN, isomer A
with three different cyclobutanes): δ=181.5 (br, C2, only detectable
by 2D NMR spectroscopy), 143.6, 143.2, 143.1 (C9, C9’, C9’’), 143.1,
142.9, 142.6, (C12, C12’, C12’’), 139.3, 139,2 (C6, C6’, C6’’), 132.7 (br,
C7, only detectable by 2D NMR spectroscopy), 130.5, 130.4, 128.5
(C13, C13’, C13’’ only detectable by 2D NMR spectroscopy), 126.0,
125.9 (C8, C8’, C8’’), 123.6, (C5), 123.1 (C4), 54.1 (C11), 53.8 (C11’),
53.7 (C11’’), 52.8 (C14), 43.9 (C10), 43.8 (C10’), 43.8 (C10’’), 34.5
(C15), 20.7 (C16), 14.1 (C17). 1H NMR (400.1 MHz, CD3CN, isomer B
with three identical cyclobutanes): δ=7.48–7.33 (m, 12H, H4, H5),
7.32–7.16 (m, 24H, H7, H8), 6.47 (s, 6H, H13), 4.73 (d, 3JH-H=6.5 Hz,
6H, H11), 4.64 (d, 3JH-H=6.5 Hz, 6H, H10), 4.32–4.22 (m, 12H, H14),
1.96–1.93 (m, 12H, H15), 1.51–1.37 (m, 12H, H16), 1.04–0.96 (m, 18H,
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H17). 13C{1H} NMR (101 MHz, DMSO-d6, isomer B with three identical
cyclobutanes): δ=181.5 (br, C2, only detectable by 2D NMR
spectroscopy), 143.5 (C9), 142.1 (C12), 139.3 (C6), 132.7 (br, C7, only
detectable by 2D NMR spectroscopy), 130.5 (C13), 126.0 (C8), 123.6
(C5), 123.1 (C4), 54.0 (C11), 52.8 (C14), 43.9 (C10), 34.5 (C15), 20.7
(C16), 14.1 (C17). HRMS (ESI, positive ions): m/z=608.5326 (100,
calcd. for [9]3+ 608.5332).
Synthesis of H6-10(BF4)6
A solution of [9](BF4)3 (120 mg, 0.058 mol) and NH4Cl (19 mg,
0.36 mmol) in MeOH (20 mL) was stirred for 2 h at 25 °C. A white
solid (AgCl) immediately precipitated. The suspension was filtered
through Celite and NH4BF4 (38 mg, 0.36 mmol) was added. The
resulting solution was stirred at 25 °C for 2 h. After this time, a
white solid precipitated, which was isolated by filtration. The solid
was brought to dryness under vacuum to give compound H6-
10(BF4)6 as a white powder. Yield: 70 mg (35 mmol, 60%). Due the
low solubility of H6-10(BF4)6, not all the carbon atom resonances
were detected in the 13C{1H} NMR spectra. NMR spectra showed
resonances for two isomeric reaction products, one with three
identical and one with three different cyclobutane-units. The two
isomers could not be separated, but the two different spin systems
were resolved by 2D 1H NMR spectroscopy. Due of the overlap
between the resonances of the two isomers, the relative amounts
of the isomers could not be determined exactly. 1H NMR (400 MHz,
DMSO-d6, isomer A with three different cyclobutanes): δ=9.72 (s,
6H, H2), 8.25 (s, 6H, H4), 8.02 (s, 6H, H5), 7.83–7.46 (m, 24H, H7, H8),
6.80 (s, 2H, H13), 6.41 (s, 2H, H13’), 5.86 (s, 2H, H13’’), 4.90 (s, 2H,
H10), 4.87 (s, 2H, H10’), 4.69 (s, 2H, H11), 4.60 (s, 2H, H10’’), 4.48 (s,
2H, H11’), 4.45 (s, 2H, H11’’), 4.22 (m, 12H, H14), 1.84 (m, 12H, H15),
1.32 (m, 12 H, H16), 0.93 (t, 3JH-H=7.5 Hz, 18H, H17).
13C{1H} NMR
(101 MHz, DMSO-d6, isomer A with three different cyclobutanes):
δ=143.4, 143.3, 142.9 (C9, C9’, C9’’, by 2D NMR), 136.8, (C12, C12’,
C12’’, by 2D NMR), 134.8 (C2), 132.5 (C6), 131.1 (C13, by 2D NMR),
129.8 (C8), 128.9 (C13’), 128.8 (C13’’), 123.3 (C4), 120.9 (C7), 120.7
(C5), 54.5, 54.0 (C11, C11’, C11’’), 49.0 (C14) 44.3 (C10, by 2D NMR),
44.2 (C10’, by 2D NMR), 44.1 (C10’’, by 2D NMR), 31.0 (C15), 18.7
(C16), 13.2 (C17). 1H NMR (400 MHz, DMSO-d6, isomer B with three
identical cyclobutanes): δ=9.72 (s, 6H, H2), 8.25 (s, 6H, H4), 8.02 (s,
6H, H5), 7.83–7.46 (m, 24H, H7, H8), 6.37 (s, 6H, H13), 4.63 (s, 12H,
H10, H11), 4.22 (m, 12H, H14), 1.84 (m, 12H, H15), 1.32 (m, 12H,
H16), 0.93 (t, 3JH-H=7.5 Hz, 18H, H17).
13C{1H} NMR (101 MHz, DMSO-
d6, isomer B with three identical clobutanes): δ=142.8 (C9, by 2D
NMR) 136.8 (C12, by 2D NMR), 134.8 (C2), 132.5 (C6), 129.8 (C8),
128.9 (C13), 123.3 (C4), 120.9 (C7), 120.7 (C5), 54.5 (C11), 49.0 (C14)
44.2 (C10, by 2D NMR), 31.0 (C15), 18.7 (C16), 13.2 (C17). HRMS (ESI,
positive ions): m/z=251.1542 (100, calcd. for [H6-10]
6+ 251.1548),
318.9866 (40, calcd. for [H6-10+BF4]
5+ 318.9872), 420.4844 (10,
calcd. for [H6-10+2BF4]4+ 420.4849), 589.31363 (8, calcd. for [H6-10
+3BF4]
3+ 589.3139), 927.4733 (8, calcd. for [H6-10+4BF4]2+
927.4727).
X-ray diffraction studies
Compound [8](BPh4)3 · 2CH3CN was obtained by stirring samples of
[8](BF4)3 (50 mg, 0.024 mmol) and NaBPh4 (25 mg, 0.073 mmol) in
acetonitrile. Crystals suitable for X-ray diffraction studies of
[8](BPh4)3 · 2MeCN were obtained by slow diffusion of diethyl ether
into a concentrated solution of [8](BPh4)3 in acetonitrile. X-ray
diffraction data were collected with an Agilent SuperNova diffrac-
tometer equipped with an Atlas CCD detector at 100(2) K using Mo
Kα (λ=0.71073 Å) radiation. Semiempirical multi-scan absorption
corrections were applied to the set. The structure solution was
found with SHELXT[18] and were refined with SHELXL[19] against jF2 j
of all data using first isotropic and later anisotropic thermal
parameters for all non-hydrogen atoms. Hydrogen atoms have
been added to the structure models on calculated positions. Crystal
data for [8](BPh4)3 · 2MeCN: Formula C178H174N14Ag3B3N14, M=
2865.36 gmol  1, colorless prism, 0.02×0.02×0.08 mm3, triclinic,
space group P-1, Z=6, a=21.0858(6), b=28.4587(8), c=
39.5416(12) Å, α=75.042(2), β=82.599(2)°, γ=76.552(2), V=
22235.5(12) Å3, 1calcd=1.284 gcm
  1, μ=0.451 mm  1, 223317 meas-
ured intensities (1.5°�2Θ�50.1°), semiempirical absorption cor-
rection (0.991�T�0.965), 78402 independent intensities (Rint=
0.0832) and 52901 observed intensities (I�2σ(I)), refinement of
5761 parameters against jF2 j of all independent intensities with
hydrogen atoms on calculated positions. R=0.0820, Rw=0.2038,
Rall=0.1226, Rw,all=0.2245. The asymmetric unit contains three
formula unit of [8](BPh4)3 and six molecules of CH3CN. In addition,
three badly disordered acetonitrile molecules were found in the
asymmetric unit. The program PLATON-SQEEZE[20] was therefore
used to remove mathematically the effect of these solvent
molecules. The quoted formula and derived parameters[21] do not
include the squeezed solvent molecules.
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